Distinct features of dendritic cell-based immunotherapy as cancer vaccines
- Author:
Chaelin LEE
1
;
Myungmi LEE
;
Inmoo RHEE
Author Information
- Publication Type:Review
- Keywords: Dendritic cells; Vaccines; Immunotherapy; Neoplasms
- MeSH: Antigen-Presenting Cells; Cancer Vaccines; Dendritic Cells; Immunotherapy; Lymphoid Tissue; T-Lymphocytes; Vaccines
- From:Clinical and Experimental Vaccine Research 2018;7(1):16-23
- CountryRepublic of Korea
- Language:English
- Abstract: Dendritic cells (DCs) are the most professional antigen presenting cells that play important roles in connection between innate and adaptive immune responses. Numerous studies revealed that the functions of DCs are related with the capture and processing of antigen as well as the migration to lymphoid tissues for the presenting antigens to T cells. These unique features of DCs allow them to be considered as therapeutic vaccines that can induce immune responses and anti-tumor activity. Here, we discuss and understand the immunological basis of DCs and presume the possibilities of DC-based vaccines for the promising cancer therapy.
